Skip to content

Clozapine

Clozapine (Clozaril) is an antipsychotic ingredient used for Treatment-resistant Schizophrenia. This page lists the sole formulation available in the catalogue: Clozaril tablets, marketed by Novartis.

Clozaril

Treatment-resistant Schizophrenia

50mg · 100mg

Clozapine tablets for treatment-resistant schizophrenia. It acts on both dopamine and serotonin receptors, and is used when other antipsychotics have not worked.

From$0.82/ tabletView

Key points

  • Clozapine works by targeting brain chemicals involved in mood and perception, which is the basis for its effect in schizophrenia.
  • The catalogue lists a single tablet formulation in two strengths: 50 mg and 100 mg.
  • Treatment with clozapine usually involves regular blood tests because of a risk of a significant drop in white blood cells.

Clozaril is the originator brand for clozapine, first developed by Novartis, and it is the only formulation listed in this catalogue. The tablets sit under the Mental Health category and are part of a specialist-managed treatment plan for schizophrenia that has not improved with other antipsychotic medicines.

Further reading